US Stock MarketDetailed Quotes

Keros Therapeutics (KROS)

Watchlist
  • 19.150
  • -0.310-1.59%
Trading Jan 23 13:48 ET
583.43MMarket Cap12.28P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Keros Therapeutics (KROS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
110.65%3.25M
25.57%-29.62M
461.69%161.17M
-29.20%-160.87M
-80.71%-46.01M
10.25%-30.5M
-29.09%-39.8M
-30.16%-44.56M
-77.71%-124.51M
-18.73%-25.46M
Net income from continuing operations
86.25%-7.28M
32.17%-30.7M
444.32%148.45M
-22.46%-187.35M
-14.37%-46.03M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-46.15%-152.99M
-35.42%-40.24M
Operating gains losses
--0
----
----
----
----
----
----
----
-66.67%4K
--0
Depreciation and amortization
25.80%395K
20.92%370K
24.19%344K
50.80%1.23M
34.41%332K
49.52%314K
60.21%306K
65.87%277K
20.92%815K
94.49%247K
Other non cash items
8.17%609K
71.97%595K
72.27%584K
17.27%1.82M
70.75%572K
65.10%563K
-2.26%346K
-35.06%339K
64.93%1.55M
4.36%335K
Change In working capital
-56.60%5.54M
-111.50%-8.42M
128.91%2.93M
-331.58%-11.44M
-246.64%-10.09M
435.49%12.76M
-336.04%-3.98M
-110.60%-10.13M
-118.52%-2.65M
123.31%6.88M
-Change in receivables
3,309.38%12.32M
564.41%1.48M
-17,428.92%-14.55M
-1,717.48%-2.6M
-1,546.15%-2.35M
---384K
--222K
---83K
-100.79%-143K
---143K
-Change in prepaid assets
-24.50%4.43M
19.89%-5.1M
201.45%4.54M
-10.05%-10.22M
-1,073.28%-5.25M
237.86%5.87M
-327.54%-6.37M
-9.92%-4.48M
-179.55%-9.28M
299.63%539K
-Change in payables and accrued expense
-239.52%-9.92M
-196.14%-2.42M
259.11%8.48M
-60.66%2.7M
-123.31%-1.59M
7,631.52%7.11M
316.75%2.51M
-713.89%-5.33M
39.82%6.87M
40.61%6.83M
-Change in other current assets
--0
1,880.77%463K
--1.59M
99.16%-4K
1.88%-469K
--491K
---26K
--0
69.63%-478K
---478K
-Change in other working capital
-291.24%-1.3M
-777.16%-2.84M
1,291.67%2.86M
-443.75%-1.32M
-429.46%-425K
-190.93%-331K
-1,100.00%-324K
-192.68%-240K
110.35%384K
108.55%129K
Cash from discontinued investing activities
Operating cash flow
110.65%3.25M
25.57%-29.62M
461.69%161.17M
-29.20%-160.87M
-80.71%-46.01M
10.25%-30.5M
-29.09%-39.8M
-30.16%-44.56M
-77.71%-124.51M
-18.73%-25.46M
Investing cash flow
Cash flow from continuing investing activities
65.80%-132K
-132.26%-720K
40.27%-565K
21.63%-1.93M
46.58%-289K
29.82%-386K
0.32%-310K
10.92%-946K
-98.55%-2.46M
-54.13%-541K
Net PPE purchase and sale
65.80%-132K
-132.26%-720K
40.27%-565K
21.63%-1.93M
46.58%-289K
29.82%-386K
0.32%-310K
10.92%-946K
-98.55%-2.46M
-54.13%-541K
Cash from discontinued investing activities
Investing cash flow
65.80%-132K
-132.26%-720K
40.27%-565K
21.63%-1.93M
46.58%-289K
29.82%-386K
0.32%-310K
10.92%-946K
-98.55%-2.46M
-54.13%-541K
Financing cash flow
Cash flow from continuing financing activities
-99.91%140K
-99.52%17K
-100.00%4K
118.95%391.82M
9.08%75.54M
54,809.86%155.94M
102.93%3.53M
45.62%156.8M
48.75%178.96M
12.76%69.25M
Net common stock issuance
-99.91%138K
--0
--0
116.20%380.13M
6.69%73.1M
--155.07M
--629K
41.03%151.34M
47.04%175.83M
11.59%68.52M
Proceeds from stock option exercised by employees
-99.80%2K
-99.43%17K
-99.93%4K
276.47%12.14M
204.10%2.45M
224.12%1.01M
70.52%2.97M
1,446.22%5.72M
294.25%3.23M
688.24%804K
Net other financing activities
----
----
----
-382.98%-454K
--0
---130K
---65K
---259K
-8.05%-94K
---67K
Cash from discontinued financing activities
Financing cash flow
-99.91%140K
-99.52%17K
-100.00%4K
118.95%391.82M
9.08%75.54M
54,809.86%155.94M
102.93%3.53M
45.62%156.8M
48.75%178.96M
12.76%69.25M
Net cash flow
Beginning cash position
69.91%691.66M
62.74%721.99M
68.91%561.38M
18.54%332.36M
84.06%532.13M
25.89%407.08M
25.77%443.66M
18.54%332.36M
21.18%280.38M
20.08%289.11M
Current changes in cash
-97.40%3.26M
17.10%-30.33M
44.31%160.61M
340.56%229.02M
-32.38%29.25M
465.15%125.06M
-24.41%-36.58M
53.76%111.3M
6.08%51.98M
9.17%43.25M
End cash Position
30.59%694.92M
69.91%691.66M
62.74%721.99M
68.91%561.38M
68.91%561.38M
84.06%532.13M
25.89%407.08M
25.77%443.66M
18.54%332.36M
18.54%332.36M
Free cash flow
110.09%3.12M
24.35%-30.34M
452.93%160.61M
-28.22%-162.8M
-78.07%-46.3M
10.56%-30.89M
-28.80%-40.11M
-28.92%-45.51M
-78.07%-126.97M
-19.30%-26M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 110.65%3.25M25.57%-29.62M461.69%161.17M-29.20%-160.87M-80.71%-46.01M10.25%-30.5M-29.09%-39.8M-30.16%-44.56M-77.71%-124.51M-18.73%-25.46M
Net income from continuing operations 86.25%-7.28M32.17%-30.7M444.32%148.45M-22.46%-187.35M-14.37%-46.03M-34.27%-52.96M-20.67%-45.26M-20.42%-43.11M-46.15%-152.99M-35.42%-40.24M
Operating gains losses --0-----------------------------66.67%4K--0
Depreciation and amortization 25.80%395K20.92%370K24.19%344K50.80%1.23M34.41%332K49.52%314K60.21%306K65.87%277K20.92%815K94.49%247K
Other non cash items 8.17%609K71.97%595K72.27%584K17.27%1.82M70.75%572K65.10%563K-2.26%346K-35.06%339K64.93%1.55M4.36%335K
Change In working capital -56.60%5.54M-111.50%-8.42M128.91%2.93M-331.58%-11.44M-246.64%-10.09M435.49%12.76M-336.04%-3.98M-110.60%-10.13M-118.52%-2.65M123.31%6.88M
-Change in receivables 3,309.38%12.32M564.41%1.48M-17,428.92%-14.55M-1,717.48%-2.6M-1,546.15%-2.35M---384K--222K---83K-100.79%-143K---143K
-Change in prepaid assets -24.50%4.43M19.89%-5.1M201.45%4.54M-10.05%-10.22M-1,073.28%-5.25M237.86%5.87M-327.54%-6.37M-9.92%-4.48M-179.55%-9.28M299.63%539K
-Change in payables and accrued expense -239.52%-9.92M-196.14%-2.42M259.11%8.48M-60.66%2.7M-123.31%-1.59M7,631.52%7.11M316.75%2.51M-713.89%-5.33M39.82%6.87M40.61%6.83M
-Change in other current assets --01,880.77%463K--1.59M99.16%-4K1.88%-469K--491K---26K--069.63%-478K---478K
-Change in other working capital -291.24%-1.3M-777.16%-2.84M1,291.67%2.86M-443.75%-1.32M-429.46%-425K-190.93%-331K-1,100.00%-324K-192.68%-240K110.35%384K108.55%129K
Cash from discontinued investing activities
Operating cash flow 110.65%3.25M25.57%-29.62M461.69%161.17M-29.20%-160.87M-80.71%-46.01M10.25%-30.5M-29.09%-39.8M-30.16%-44.56M-77.71%-124.51M-18.73%-25.46M
Investing cash flow
Cash flow from continuing investing activities 65.80%-132K-132.26%-720K40.27%-565K21.63%-1.93M46.58%-289K29.82%-386K0.32%-310K10.92%-946K-98.55%-2.46M-54.13%-541K
Net PPE purchase and sale 65.80%-132K-132.26%-720K40.27%-565K21.63%-1.93M46.58%-289K29.82%-386K0.32%-310K10.92%-946K-98.55%-2.46M-54.13%-541K
Cash from discontinued investing activities
Investing cash flow 65.80%-132K-132.26%-720K40.27%-565K21.63%-1.93M46.58%-289K29.82%-386K0.32%-310K10.92%-946K-98.55%-2.46M-54.13%-541K
Financing cash flow
Cash flow from continuing financing activities -99.91%140K-99.52%17K-100.00%4K118.95%391.82M9.08%75.54M54,809.86%155.94M102.93%3.53M45.62%156.8M48.75%178.96M12.76%69.25M
Net common stock issuance -99.91%138K--0--0116.20%380.13M6.69%73.1M--155.07M--629K41.03%151.34M47.04%175.83M11.59%68.52M
Proceeds from stock option exercised by employees -99.80%2K-99.43%17K-99.93%4K276.47%12.14M204.10%2.45M224.12%1.01M70.52%2.97M1,446.22%5.72M294.25%3.23M688.24%804K
Net other financing activities -------------382.98%-454K--0---130K---65K---259K-8.05%-94K---67K
Cash from discontinued financing activities
Financing cash flow -99.91%140K-99.52%17K-100.00%4K118.95%391.82M9.08%75.54M54,809.86%155.94M102.93%3.53M45.62%156.8M48.75%178.96M12.76%69.25M
Net cash flow
Beginning cash position 69.91%691.66M62.74%721.99M68.91%561.38M18.54%332.36M84.06%532.13M25.89%407.08M25.77%443.66M18.54%332.36M21.18%280.38M20.08%289.11M
Current changes in cash -97.40%3.26M17.10%-30.33M44.31%160.61M340.56%229.02M-32.38%29.25M465.15%125.06M-24.41%-36.58M53.76%111.3M6.08%51.98M9.17%43.25M
End cash Position 30.59%694.92M69.91%691.66M62.74%721.99M68.91%561.38M68.91%561.38M84.06%532.13M25.89%407.08M25.77%443.66M18.54%332.36M18.54%332.36M
Free cash flow 110.09%3.12M24.35%-30.34M452.93%160.61M-28.22%-162.8M-78.07%-46.3M10.56%-30.89M-28.80%-40.11M-28.92%-45.51M-78.07%-126.97M-19.30%-26M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.87%
Sample Name
Sample Code
 +2.94%
Sample Name
Sample Code
 +2.63%
4
Netflix
NFLX
+2.40%
5
Amazon
AMZN
+2.01%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.27%
Sample Name
Sample Code
 +8.58%
Sample Name
Sample Code
 +4.42%
4
H World Group
HTHT
+4.37%
5
KE Holdings
BEKE
+4.36%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -